These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 15919938

  • 1. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
    Stittelaar KJ, van Amerongen G, Kondova I, Kuiken T, van Lavieren RF, Pistoor FH, Niesters HG, van Doornum G, van der Zeijst BA, Mateo L, Chaplin PJ, Osterhaus AD.
    J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
    Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, Eisenberg RJ, Hartmann CJ, Jackson DL, Kulesh DA, Martinez MJ, Miller DM, Mucker EM, Shamblin JD, Zwiers SH, Huggins JW, Jahrling PB, Moss B.
    Nature; 2004 Mar 11; 428(6979):182-5. PubMed ID: 15014500
    [Abstract] [Full Text] [Related]

  • 3. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
    Edghill-Smith Y, Bray M, Whitehouse CA, Miller D, Mucker E, Manischewitz J, King LR, Robert-Guroff M, Hryniewicz A, Venzon D, Meseda C, Weir J, Nalca A, Livingston V, Wells J, Lewis MG, Huggins J, Zwiers SH, Golding H, Franchini G.
    J Infect Dis; 2005 Feb 01; 191(3):372-81. PubMed ID: 15633096
    [Abstract] [Full Text] [Related]

  • 4. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.
    Virology; 2005 Sep 01; 339(2):164-75. PubMed ID: 15993917
    [Abstract] [Full Text] [Related]

  • 5. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.
    J Virol; 2004 May 01; 78(9):4433-43. PubMed ID: 15078924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
    Stittelaar KJ, Neyts J, Naesens L, van Amerongen G, van Lavieren RF, Holý A, De Clercq E, Niesters HG, Fries E, Maas C, Mulder PG, van der Zeijst BA, Osterhaus AD.
    Nature; 2006 Feb 09; 439(7077):745-8. PubMed ID: 16341204
    [Abstract] [Full Text] [Related]

  • 8. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
    Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S, Peters E, Rhodes L, Spano YE, Silvera PM, Moss B.
    Proc Natl Acad Sci U S A; 2008 Aug 05; 105(31):10889-94. PubMed ID: 18678911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
    Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, Reimann KA, Franchini G.
    Nat Med; 2005 Jul 05; 11(7):740-7. PubMed ID: 15951823
    [Abstract] [Full Text] [Related]

  • 12. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuss T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G.
    J Infect Dis; 2009 Jan 01; 199(1):39-48. PubMed ID: 19012492
    [Abstract] [Full Text] [Related]

  • 13. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M, Pacchioni SM, Zanotto C, De Giuli Morghen C, Illiano E, Granucci F, Zanoni I, Broggi A, Radaelli A.
    Virus Res; 2013 Dec 26; 178(2):374-82. PubMed ID: 24050999
    [Abstract] [Full Text] [Related]

  • 14. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
    Nigam P, Earl PL, Americo JL, Sharma S, Wyatt LS, Edghill-Spano Y, Chennareddi LS, Silvera P, Moss B, Robinson HL, Amara RR.
    Virology; 2007 Sep 15; 366(1):73-83. PubMed ID: 17507071
    [Abstract] [Full Text] [Related]

  • 15. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
    Drexler I, Staib C, Kastenmuller W, Stevanović S, Schmidt B, Lemonnier FA, Rammensee HG, Busch DH, Bernhard H, Erfle V, Sutter G.
    Proc Natl Acad Sci U S A; 2003 Jan 07; 100(1):217-22. PubMed ID: 12518065
    [Abstract] [Full Text] [Related]

  • 16. Subunit recombinant vaccine protects against monkeypox.
    Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G.
    J Immunol; 2006 Aug 15; 177(4):2552-64. PubMed ID: 16888017
    [Abstract] [Full Text] [Related]

  • 17. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
    Edghill-Smith Y, Venzon D, Karpova T, McNally J, Nacsa J, Tsai WP, Tryniszewska E, Moniuszko M, Manischewitz J, King LR, Snodgrass SJ, Parrish J, Markham P, Sowers M, Martin D, Lewis MG, Berzofsky JA, Belyakov IM, Moss B, Tartaglia J, Bray M, Hirsch V, Golding H, Franchini G.
    J Infect Dis; 2003 Oct 15; 188(8):1181-91. PubMed ID: 14551889
    [Abstract] [Full Text] [Related]

  • 18. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
    Coulibaly S, Brühl P, Mayrhofer J, Schmid K, Gerencer M, Falkner FG.
    Virology; 2005 Oct 10; 341(1):91-101. PubMed ID: 16061267
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL, Gates AJ, Hillier M, Eastaugh L, Ulaeto DO.
    Vaccine; 2007 Jan 02; 25(1):34-42. PubMed ID: 16950548
    [Abstract] [Full Text] [Related]

  • 20. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques.
    Goff AJ, Chapman J, Foster C, Wlazlowski C, Shamblin J, Lin K, Kreiselmeier N, Mucker E, Paragas J, Lawler J, Hensley L.
    J Virol; 2011 May 02; 85(10):4898-909. PubMed ID: 21389129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.